Your browser doesn't support javascript.
loading
Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs. placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1.
Mateos, María-Victoria; Masszi, Tamas; Grzasko, Norbert; Hansson, Markus; Sandhu, Irwindeep; Pour, Ludek; Viterbo, Luísa; Jackson, Sharon R; Stoppa, Anne-Marie; Gimsing, Peter; Hamadani, Mehdi; Borsaru, Gabriela; Berg, Deborah; Lin, Jianchang; Di Bacco, Alessandra; van de Velde, Helgi; Richardson, Paul G; Moreau, Philippe.
Afiliação
  • Mateos MV; Hospital Universitario de Salamanca, Instituto Biosanitario de Salamanca (IBSAL), Spain.
  • Masszi T; St. István, St. László Hospital, 3 Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Grzasko N; Medical University of Lublin and St John's Cancer Center, Lublin, Poland.
  • Hansson M; Skåne University Hospital, Lund University, Sweden.
  • Sandhu I; University of Alberta Edmonton, Canada.
  • Pour L; University Hospital Brno, Czech Republic.
  • Viterbo L; Instituto Português de Oncologia do Porto Francisco Gentil, Entidade Pública Empresarial (IPOPFG, EPE), Portugal.
  • Jackson SR; Middlemore Hospital, Auckland, New Zealand.
  • Stoppa AM; Institut Paoli-Calmettes, Marseille, France.
  • Gimsing P; University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Hamadani M; Medical College of Wisconsin, Milwaukee, WI, USA.
  • Borsaru G; Spitalul Clinic Coltea, Bucharest, Romania.
  • Berg D; Millennium Pharmaceuticals Inc., Cambridge, MA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • Lin J; Millennium Pharmaceuticals Inc., Cambridge, MA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • Di Bacco A; Millennium Pharmaceuticals Inc., Cambridge, MA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • van de Velde H; Millennium Pharmaceuticals Inc., Cambridge, MA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • Richardson PG; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Moreau P; University Hospital Hôtel Dieu, Nantes, France.
Haematologica ; 102(10): 1767-1775, 2017 10.
Article em En | MEDLINE | ID: mdl-28751562
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Idioma: En Ano de publicação: 2017 Tipo de documento: Article